MindMed Engages in Key Industry Events for Brain Health
Company Announcements

MindMed Engages in Key Industry Events for Brain Health

Story Highlights

Mind Medicine (MNMD) has released an update.

Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, is set to engage in major industry events come June 2024. The company will discuss challenges in neuropsychiatric drug innovation at the BIO International Convention in San Diego and hold investor meetings at the Jefferies Global Healthcare Conference in New York.

For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyMind Medicine price target raised to $16 from $14 at Canaccord
TipRanks Auto-Generated NewsdeskMindMed Advances Phase 3 Trials in Mental Health
TipRanks Canadian Auto-Generated NewsdeskMind Medicine’s Financial Health and Phase 3 Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App